Introduction: Tumour grade and hepatic metastases are negative prognostic factors for advanced small bowel neuroendocrine tumours (SBNETs), but data assessing other prognosticators at diagnosis (Dx) are lacking.
Aim(s): To assess impact on survival of combined clinical and biochemical factors at time of Dx.
Materials and methods: 572 patients with advanced SBNETs including symptoms at Dx, carcinoid heart disease (CHD), biomarkers and initial treatment were retrospectively analysed, using Cox proportional hazards models.
Conference: 13th Annual ENETS conference 2016 (2016)
Category: Epidemiology/Natural history/Prognosis - Prognosis
Presenting Author: Dr Christos Toumpanakis
, Vlachou E
, Ramakrishnan S
, Phillips E
, Tuck A
, Wilkins D
, Gertner J
, Hernandez J G
, Mullan M
, Theocharidou E
, Caplin M
To read results and conclusion, please login ...
Further abstracts you may be interested in